GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
125 hedge funds and large institutions have $434M invested in G1 Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
125
Holders Change
+7
Holders Change %
+5.93%
% of All Funds
2.22%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
47
Reduced
43
Closed
10
Calls
$2.54M
Puts
$7.12M
Net Calls
-$4.58M
Net Calls Change
-$2.81M
Top Buyers
| 1 |
1
Two Sigma Advisers
New York
|
$8.63M |
| 2 |
2
Invesco
Atlanta,
Georgia
|
$12.2M |
| 3 |
3
Nuveen Asset Management
Chicago,
Illinois
|
$12.3M |
| 4 |
4
BlackRock
New York
|
$52.1M |
| 5 |
5
Voloridge Investment Management
Jupiter,
Florida
|
$4.66M |
